May 17
New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments.
read more
Popularity: unranked [?]
Original post by kb
Popularity: 5% [?]
Recent Comments